Manuel M. Caamaño
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manuel M. Caamaño has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Enrique Casado
Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA). Universitat Autònoma de Barcelona (UAB), Sabadell, Spain
2 shared publications Esteban Salas
1 shared publication- Gabriel Herrero-Beaumont
Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Madrid, Spain
1 shared publication - Jenaro Graña
Complejo Hospitalario Universitario de A Coruña, 15006 A Coruña, Spain
1 shared publication - Jesús Muñoz-Rodriguez
Department of Urology, Hospital Universitari Parc Taulí, Sabadell, Spain
1 shared publication - Jorge Malouf
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by XMLink in The World Journal of Men's Health
- Vol. 40 (1) , 74-86
Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
Casado E, et al. World J Mens Health. 2022 Jan;40(1):74-86. https://doi.org/10.5534/wjmh.210061
- 1 January 2022
- Published by XMLink in The World Journal of Men's Health
- Vol. 40 (1) , 74-86
Open AccessMultidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
Casado E, et al. World J Mens Health. 2022 Jan;40(1):74-86. https://doi.org/10.5534/wjmh.210061
- 1 August 2011
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 17 (5) , S59-S66
Defining High Risk of Osteoporotic Fracture
Background: There is no universally accepted definition for patients at high risk of osteoporotic fracture. Objectives: This study aimed to survey Spanish rheumatologists; to obtain opinions about risk factors, and an acceptable definition for patients at high risk of osteoporotic fracture; and to compare daily practice patterns with current osteoporosis guidelines. Methods: A total of 174 rheumatologists from throughout Spain completed an online survey about various risk factors for fragility fracture and about the management of patients with osteoporosis in clinical practice. Results were reviewed by a coordinating committee of osteoporosis experts and were compared with published national and international guideline recommendations. Results: Almost all rheumatologists who completed the survey (99%) consider that a group of patients exists with a high risk of osteoporotic fracture and that this group should be managed appropriately. Previous fracture is considered the most important risk factor, particularly in cases of multiple fracture, severe vertebral fracture, hip fracture, or fracture despite osteoporosis treatment. However, in osteoporosis guidelines, age, bone mineral density, and previous fragility fracture are the most important risk factors for new fracture. Furthermore, Spanish rheumatologists tend to treat patients at high risk of fracture with anabolic therapy (e.g., teriparatide), whereas guidelines make no such recommendation. Conclusions: In osteoporosis, a large gap exists between implementation of guideline recommendations and actual clinical practice; this may be due, in part, to heterogeneity among existing guidelines. Thus, inclusion in guidelines of a practical definition of high risk of osteoporotic fracture may provide significant opportunities to improve patient care and prevent future fragility fractures. Key Points: In osteoporosis, there is a gap between guideline recommendations and current clinical practice regarding the identification of risk factors for future fracture. Lack of consensus about `high risk' definition between available guidelines, and difficulties in interpreting guideline recommendations, may contribute to this gap between rheumatologists' practice and guidelines. Patients at high risk of fracture are detected too late, thus leading to suboptimal health care delivery. Defining a clinical profile for high-risk patients provides an opportunity to facilitate the decision-making process and improve patient care in osteoporosis.
- 1 August 2011
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 17 (5) , S59-S66
Defining High Risk of Osteoporotic Fracture
Background: There is no universally accepted definition for patients at high risk of osteoporotic fracture. Objectives: This study aimed to survey Spanish rheumatologists; to obtain opinions about risk factors, and an acceptable definition for patients at high risk of osteoporotic fracture; and to compare daily practice patterns with current osteoporosis guidelines. Methods: A total of 174 rheumatologists from throughout Spain completed an online survey about various risk factors for fragility fracture and about the management of patients with osteoporosis in clinical practice. Results were reviewed by a coordinating committee of osteoporosis experts and were compared with published national and international guideline recommendations. Results: Almost all rheumatologists who completed the survey (99%) consider that a group of patients exists with a high risk of osteoporotic fracture and that this group should be managed appropriately. Previous fracture is considered the most important risk factor, particularly in cases of multiple fracture, severe vertebral fracture, hip fracture, or fracture despite osteoporosis treatment. However, in osteoporosis guidelines, age, bone mineral density, and previous fragility fracture are the most important risk factors for new fracture. Furthermore, Spanish rheumatologists tend to treat patients at high risk of fracture with anabolic therapy (e.g., teriparatide), whereas guidelines make no such recommendation. Conclusions: In osteoporosis, a large gap exists between implementation of guideline recommendations and actual clinical practice; this may be due, in part, to heterogeneity among existing guidelines. Thus, inclusion in guidelines of a practical definition of high risk of osteoporotic fracture may provide significant opportunities to improve patient care and prevent future fragility fractures. Key Points: In osteoporosis, there is a gap between guideline recommendations and current clinical practice regarding the identification of risk factors for future fracture. Lack of consensus about `high risk' definition between available guidelines, and difficulties in interpreting guideline recommendations, may contribute to this gap between rheumatologists' practice and guidelines. Patients at high risk of fracture are detected too late, thus leading to suboptimal health care delivery. Defining a clinical profile for high-risk patients provides an opportunity to facilitate the decision-making process and improve patient care in osteoporosis.